References
- Anonymous. Report from the PHLS communicable disease surveillance center. Br Med J 1986; 292: 1447–1449
- Control of communicable diseases, 15th ed., A S Benenson. American Public Health Association, Washington 1990; 280–284
- Gaunt P N. Ciprofloxacin vs ceftriaxone for eradication of meningococcal carriage. Lancet 1988; 1: 218–219
- Bøvre K, Gedde-Dahl T W. Epidemiological patterns of meningococcal disease in Norway 1975–1979. NIPH Annals 1980; 3: 9–23
- Høiby E A, Moe P J, Lystad A, Frøholm L O. Phenoxymethylpenicillin treatment of household contacts of meningococcal disease patients. Antonie Van Leeuwenhoek 1986; 52: 255–257
- Dowd J M, Blink D, Miller C H, Frank P F, Pierce W E. Antibiotic prophylaxis of carriers of sulfadiazine-resistant meningococci. J Infect Dis 1966; 116: 473–480
- Beaty H N. Rifampicin and minocycline in meningococcal disease. Rev Infect Dis 1983, Suppl 5: S451–S458
- Munford R S, Taunay A E, deMorais J S, Fraser D W, Feldman R A. Spread of meningococcal infection within households. Lancet 1974; 1: 1275–1278
- Bjorvatn B, Lund V, Kristiansen B E, Korsnes L, Spanne O, Lindqvist B H. Applications of restriction endonuclease fingerprinting of chromosomal DNA of Neisseria meningitidis. J Clin Microbiol 1984; 19: 763–765
- Kristiansen B E, Sørensen B, Bjorvatn B, Falk E, Fosse E, Bryn K, Frøholm L O, Gaustad P, Bøvre K. An outbreak of group B meningococcal disease: tracing the causative strain of Neisseria meningitidis by DNA fingerprinting. J Clin Microbiol 1986; 23: 764–767
- Kristiansen B E, Lind K W, Mevold K, Sørensen B, Frøholm L O, Bryn K, Tjade T, Bøvre K. Meningococcal carriage: studies of bacterial phenotypic and genomic characteristics and of human phenotypic and genomic characteristics and of human antibody levels. J Clin Microbiol 1988; 26: 1988–1992
- Kristiansen B E, Sørensen B, Simonsen T, Spanne O, Lund V, Bjorvatn B. Isolates of Neisseria meningitidis from different sites of the same patient: phenotypic and genomic studies, with special reference to adherence, piliation and DNA restriction endonuclease pattern. J Infect Dis 1984; 150: 389–396
- Olcén P, Kjellander J, Danielsson D, Lindquist B L. Epidemiology of Neisseria meningitidis: Prevalence and symptoms from the upper respiratory tract in family members to patients with meningococcal disease. Scand J Infect Dis 1981; 13: 105–109
- Cooke R PD, Riordan T, Jones D M, Painter M J. Secondary cases of meningococcal infection among close family and household contacts in England and Wales, 1984–7. Br Med J 1989; 298: 555–558
- Stuart J M, Cartwright K AV, Robinson P M, Noah N D. Does eradication of meningococcal carriage in household contacts prevent secondary cases of meningococcal disease?. Br Med J 1989; 298: 569–570
- Weihe P, Mathiassen B, Rasmussen J M, Petersen T, Isager H. An epidemic outbreak of group B meningococcal disease on the Faroe Islands. Scand J Infect Dis 1988; 20: 291–296
- Levy D I, del Rio C, Stephens D S. Meningococcemia in identical twins: changes in serum susceptibility after rifampicin chemoprophylaxis. J Infect Dis 1988; 157: 1064–1068
- Kristiansen B E, Rådström P, Jenkins A, Ask E, Facinelli B, Sköld O. Cloning and characterization of a DNA fragment that confers sulfonamide resistance in a serogroup B, serotype 15 strain of Neisseria meningitidis. Antimicrob Agents Chemother 1991; 34: 2277–2279
- Kristiansen B E, Ask E, Jenkins A, Fermer C, Rådström P, Sköld O. Rapid diagnosis of meningococcal meningitis by polymerase chain reaction. Lancet 1991; 1: 1568–1569